Holding(s) in Company | 30-Dec-2021 | 11:35 | RNS |
Grant of Options | 08-Dec-2021 | 14:08 | RNS |
Half-year Report | 07-Dec-2021 | 07:00 | RNS |
Notice of Results | 23-Nov-2021 | 07:00 | RNS |
Publication of data on SFX-01 in glioblastoma | 10-Nov-2021 | 07:00 | RNS |
Holding(s) in Company | 19-Oct-2021 | 14:39 | RNS |
Holding(s) in Company | 02-Sep-2021 | 14:32 | RNS |
Second Price Monitoring Extn | 02-Sep-2021 | 14:06 | RNS |
Price Monitoring Extension | 02-Sep-2021 | 14:00 | RNS |
Second Price Monitoring Extn | 02-Sep-2021 | 11:05 | RNS |
Glioma Orphan Drug designation granted by FDA | 02-Sep-2021 | 11:01 | RNS |
Price Monitoring Extension | 02-Sep-2021 | 11:00 | RNS |
Holding(s) in Company | 25-Aug-2021 | 16:42 | RNS |
Second Price Monitoring Extn | 24-Aug-2021 | 16:41 | RNS |
Price Monitoring Extension | 24-Aug-2021 | 16:36 | RNS |
Currency | UK Pounds |
Share Price | 0.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 4.05 |
52 Week Low | 0.72 |
Volume | 7,200 |
Shares Issued | 427.35m |
Market Cap | £3.21m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research